Ondine Biomedical Inc. (AIM:OBI)

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
aPDT Products	2.65M	2.05M	1.20M	638.00K	2.57M
aPDT Products Growth	29.14%	70.32%	88.56%	-75.17%	43.44%
Total	2.65M	2.05M	1.20M	638.00K	2.57M
Total Growth	29.14%	70.32%	88.56%	-75.17%	43.44%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Canada	2.13M	1.97M	1.12M	596.00K	2.50M
Canada Growth	8.23%	75.18%	88.59%	-76.17%	42.59%
United Kingdom	567.00K	45.00K	-	-	-
United Kingdom Growth	1160.00%	-	-	-	-
Other	-52.00K	35.00K	79.00K	42.00K	68.00K
Other Growth	-	-55.70%	88.10%	-38.24%	83.78%
Total	2.65M	2.05M	1.20M	638.00K	2.57M
Total Growth	29.14%	70.32%	88.56%	-75.17%	43.44%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 2, 2026

Data Sources Report a data error